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Abstract
Transposable elements, or transposons, have played a significant role in the history of biological
research. They have had a major influence on the structure of genomes during evolution, they can
cause mutations, and their study led to the concept of so-called "selfish DNA". In addition,
transposons have been manipulated as useful gene transfer vectors. While primarily restricted to
use in invertebrates, prokaryotes, and plants, it is now clear that transposon technology and biology
are just as relevant to the study of vertebrate species. Multiple transposons now have been shown
to be active in vertebrates and they can be used for germline transgenesis, somatic cell transgenesis/
gene therapy, and random germline insertional mutagenesis. The sophistication of these
applications and the number of active elements are likely to increase over the next several years.
This review covers the vertebrate-active retrotransposons and transposons that have been well
studied and adapted for use as gene transfer agents. General considerations and predictions about
the future utility of transposon technology are discussed.
Introduction
"One man's trash is another man's treasure." Anonymous
Many vertebrate genomes, including the human genome,
are littered with trash, in the form of so-called "junk
DNA". Only a small portion of most vertebrate genomes
has an obvious biological role for the organism, such as
protein encoding open reading frames, untranslated
regions (UTR) of mRNA encoding DNA, promoter
sequences, or ribosomal RNA encoding DNA. Instead, the
vast majority of vertebrate genomic DNA has no obvious
function and is indeed dominated by the presence of
repetitive DNA elements that are themselves the remnants
of transposable elements or the result of transposable ele-
ment activity. Some of these elements have become inac-
tive during the evolution of today's species, some are
dependent upon enzymes encoded in trans by other trans-
posable elements, and some remain active. These
sequences are interesting for a variety of reasons. They can
be used as markers of a species evolutionary history, they
can be involved in the creation and destruction of genes,
transposase genes have been "adopted" by some organ-
isms to perform vital cellular functions (such as V-D-J
recombination), and finally, transposons have been used
as a source of vectors for transgenesis and mutagenesis in
multiple species. It is this last feature of transposable ele-
ments, in particular their use in vertebrate species, that is
the concern of this review. While the history of transpo-
son study and vector development for use in bacteria,
fungi, plant, and various invertebrate species is very long,
it has been only very recently that transposable elements
have demonstrated effectiveness as genetic tools in verte-
brate species. We speculate that these elements will
become important tools for vertebrate germline
Published: 07 November 2003
Reproductive Biology and Endocrinology 2003, 1:80
Received: 15 July 2003
Accepted: 07 November 2003
This article is available from: http://www.rbej.com/content/1/1/80
© 2003 Largaespada; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all 
media for any purpose, provided this notice is preserved along with the article's original URL.Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/80
Page 2 of 10
(page number not for citation purposes)
transgenesis, somatic and germline mutagenesis, and
human gene therapy.
Transposable Elements
Many excellent reviews have been written on the subject
of transposable elements and it is not the goal of this
review to systematically cover that very large field, which
really would require a textbook to do the subject justice
[1–3]. It can be said, however, that transposons come in
two general types (Figure 1). The "copy and paste" retro-
transposons are mobilized by transcribing an RNA copy,
that then becomes reverse transcribed and is integrated
elsewhere in the genome. In contrast, the "cut and paste"
transposable elements transpose by the direct excision
from DNA and insertion elsewhere in the genome. Both
types of elements have now been used in vertebrate cell
lines and animals as gene transfer vectors. Retrotrans-
posons come in many classes and include retroviruses,
which will not be considered in this review. Retrotranspo-
son elements require at a minimum, an internal promoter
and coding sequences for an integrase and reverse tran-
scriptase protein. Many of these elements encode proteins
that act primarily in cis, on the RNA transcript from which
they were translated. Thus, in biotechnology applications,
foreign gene sequences must be added to the 3' untrans-
lated region (UTR) of the retrotransposon vector (Figure
1). In contrast, the cut and paste transposases can act in
trans. These elements have an internal promoter and
encode a single protein "transposase" which binds to ter-
minal repeat sequences on the ends of the element, caus-
ing it to be excised and inserted elsewhere. Because the cut
and paste transposons can act in trans, it is feasible to sup-
ply the transposase by a variety of methods (DNA, RNA
and possibly transferred protein) and insert any desired
sequence in the transposon vector DNA itself (Figure 1).
These sequences might include genes for germline or
somatic cell transgenesis, sequences for insertional muta-
genesis, or recognition by site-specific recombinases.
What follows is a review of recent success in developing
vertebrate gene transfer vectors based on retrotransposons
or DNA transposons. Currently these vector systems are at
different levels of development and come from a variety
of sources (Table 1). Some are elements taken from inver-
tebrate species and adapted for use in vertebrates. Some
are endogenous, naturally active vertebrate elements,
while one was "reconstructed" from study of a large
number of endogenous defective elements. Some of these
vector systems have been shown to be effective for germ-
line and somatic cell transgenesis in vivo, while others
have so far only been shown to be active in cultured ver-
tebrate cell lines. Finally, some have been introduced into
transgenic mice and been mobilized from chromosomally
resident positions. Thus, the transposons may be useful as
general germline insertional mutagens. It is clear that mul-
tiple transposons, derived from various sources, might
find utility for generating and manipulating transgenic
animals. Because each vector system has advantages and
disadvantages, depending on the specific application,
multiple vector systems should be developed for use in
the future.
"Copy-and-paste" and "cut-and-paste" transposons have been  adapted for use as gene transfer vectors Figure 1
"Copy-and-paste" and "cut-and-paste" transposons have been 
adapted for use as gene transfer vectors. In the top half of 
the figure, transposition of naturally occurring transposons is 
depicted. In the lower half of the figure, the general methods 
used to adapt these transposons for use as gene transfer 
agents is shown. Direct terminal repeats (TR) flank some ret-
rotransposons. Inverted terminal repeats (IR) flank cut and 
paste transposons. Retrotransposons, such as the L1 ele-
ment, encode open reading frames (ORF) of unknown func-
tion as well as integrases (IN) and reverse transcriptases 
(RT). Both kinds of elements can be manipulated so that spe-
cial vector sequences are inserted. In the case of retrotrans-
posons, the vector sequences are inserted into the 3' 
untranslated region. In the case of the "cut and paste", DNA 
transposons, the vector sequences replace the transposase 
gene, which is expressed from a heterologous promoter in 
trans.Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/80
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General Considerations for Transposable Elements in 
Scientific and Biotechnology Applications
Transposons have the useful property of catalyzing the
most important step in gene transfer applications, the
insertion of foreign DNA into host chromosomes. A vari-
ety of uses for transposons in vertebrate science and bio-
technology can be imagined. However, so far three
general uses have been explored: germline transgenesis,
somatic cell transgenesis/gene therapy, and random inser-
tional mutagenesis (Figure 2).
First of all, germline transgenesis by transposition has
been developed for certain of the transposon systems that
are active in vertebrates. This has involved the co-delivery
of in vitro transcribed mRNA encoding the transposase
with transposon vector DNA into early embryos of the
frog, Xenopus tropicailis, the zebrafish Dana rario, or the
mouse (Paul Mead and Steve Ekker, personal communica-
tion) [4]. In the case of mariner-mediated transformation
of the chicken germline, an active autonomous DNA ele-
ment was injected [5]. It remains to be determined if
Table 1: Transposable elements active in vertebrate species for use as gene transfer and insertional mutagenesis vectors.
Transposon Familya Activity in cultured cellsb Activity in vertebrate animalsc References
L1 LINE retrotransposon Mouse (PCT) Human (PCT) Mouse (TCRG) [21,22]
Tol2 hAT Mouse (EP) Human (EP) Medaka (TCRG) Zebrafish (TCRG). [27,28,32]
Tc1 Tc1/mariner Human (PCT) Mouse (PCT) - [19,39,40]
Tc3 Tc1/mariner Human (PCT) Zebrafish (GT and TCRG) [19,42]
Mariner (Himar1) Tc1/mariner Human (IPT) - [19,44]
Mariner (Mos1) Tc1/mariner Human (PCT) Chicken (GT), zebrafish (GT) [5,19,43]
Minos Tc1/mariner Human (PCT) Mouse (TCRG) Mouse (TCRS) [46–48]
Sleeping Beauty Tc1/mariner Mouse, hamster, human, monkey, 
dog, cow, sheep, quail, Xenopus, 
many fish (PCT)
Mouse (GT) Mouse lung, liver 
(SCT) Mouse (TCRG) Mouse 
(TCRS)
[4,19,30,51,53–56,59,60]
aRelevant superfamily of transposable element. bActivity in immortalized cell lines has been demonstrated using by demonstrating excision from an 
introduced plasmid (EP), interplasmid transposition (IPT), or full transposition from introduced plasmid (or viral vector) into chromosomes (PCT). 
cActivity in intact animals (various species) has been demonstrated by germline transgenesis (GT), somatic cell transgenesis (SCT), transposition of 
chromosomally resident transposon vectors in the germline (TCRG), and transposition of chromosomally resident transposon vectors in the soma 
(TCRS).
General uses for transposon vectors in the generation and manipulation of transgenic animals Figure 2
General uses for transposon vectors in the generation and manipulation of transgenic animals. Many uses can be imagined for 
transposon systems that are active in vertebrates. Three of the main uses are shown here.Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/80
Page 4 of 10
(page number not for citation purposes)
transgenesis in commercially important species such as
the chicken, pig, goat or cow can be improved using trans-
posons, but this area is certainly worth exploring given the
success in diverse species so far. Given the complexities of
harvesting fertilized embryos from large animals, thought
also should be given to sperm transgenesis, since this may
offer many practical benefits. Certain advantages can be
imagined for achieving germline transgenesis by transpo-
sition, as compared to standard pronuclear injection of
DNA. One advantage is the ability, in some cases, to gen-
erate offspring with multiple independent insertions that
can then be segregated by breeding, thus increasing the
number of total potentially useful transgenesis events.
Standard pronuclear injection of linear DNA into
embryos results in concatomerization of the DNA and
random integration into the genome. However, these con-
catomer integration events are often associated with inver-
sions, deletions or other large rearrangements of DNA at
the integration site. Indeed, for this reason, up to 10% of
all mouse germline transgenics have a distinct phenotype
in the homozygous state due to insertional mutation/
deletion of endogenous genes [6]. Although these events
have allowed the identification of important endogenous
genes, it is in general an undesired effect of germline trans-
genesis. The ability of transposons to deliver a specific
fragment of DNA into a target site without alteration of
endogenous sequences, other than the insertion of the
transposon vector, could thus be considered an advan-
tage. One disadvantage of transgenesis by transposition,
could be the fact that multiple copies of a transgene can-
not be integrated into one position by transgenesis, and so
it may be difficult in some cases to achieve very high
expression of transgenes by this method. Very low expres-
sion is a frequent problem for any transgenic project.
Since transgene arrays are often subject to partial methyl-
ation and inactivation, as well as other mechanisms of
silencing, often only a multicopy array can achieve expres-
sion levels rivaling the endogenous gene. That is, small
transgene vectors typically express at a level that is only a
fraction of the level of the native gene. Nevertheless, ver-
tebrate germline transgenesis and expression has been
achieved using transposons [4]. Important considerations
for the use of transposons for germline transgenesis are
the carrying capacity of the transposon vector, its ability to
generate multiple, independent insertion events in one
embryo, the tendency of introduced genes to be expressed
within such vectors, and target site choice for integration.
Obviously, vectors that can tolerate large DNA inserts
have the advantage of allowing large cDNAs and regula-
tory sequences or multiple genes to be co-integrated at
one position. As mentioned above, if multiple insertions
per embryo are generated, then the total number of inde-
pendent transgenesis events is increased, perhaps increas-
ing the chance that one can be found which expresses at
the desired level. Another important, but so far largely
unexplored issue, is the effect of transposon vector
sequences on transgene expression. It remains possible
that inverted terminal repeat sequences from these vectors
would be recognized by host cell machinery as repetitive
sequence and thus genes in cis could be silenced by meth-
ylation. For this reason, and to avoid mobilization of
endogenous elements, it may be best to use transposons
in vertebrate species that have been isolated from very dis-
tantly related species. Finally, the tendency of a given
transposon system to integrate vector DNA in transcribed
versus non-transcribed chromatin may affect the overall
transgene expression rate and tendency to mutate endog-
enous genes by insertion.
A second application of transposons is the introduction of
transgenes directly into somatic cells of animals. Again,
transposons offer the advantage of overcoming the most
important barrier to gene transfer, that is, the stable inte-
gration of foreign DNA into the host cell chromosome.
Much of this work done in this setting has been directed
at eventual human gene therapy. Indeed, much of this
work is very promising. It is worth considering other
applications of somatic cell transgenesis however. In
mouse cancer research, it sometimes would be desirable
to avoid germline transgenesis and test the effect of trans-
genes directly in somatic cells. Not only might this allow
many genes or gene versions to be tested for oncogenic
ability, it also has the advantage of more faithfully mim-
icking human tumor development, in which genetically
distinct clones are initiated and progress in an environ-
ment of normal tissue. Another application for somatic
cell gene transfer could be in the area of biotechnology. It
is usually assumed that animal bioreactors for the produc-
tion of foreign proteins, for example in the milk of trans-
genic goats or cows, will be produced by germline
transgenesis. However, it may be faster and more direct to
introduce genes encoding these useful proteins, such as
monoclonal antibodies, clotting factors, growth factors or
other proteins, by introduction into appropriate somatic
cells of large animals. Nevertheless, the largest body of
work on transposons for somatic cell gene transfer has
been done in mice, but for the eventual application in
human gene therapy. The use of transposons for human
gene therapy has some advantages over viral gene therapy
and traditional non-viral or DNA-based gene therapy.
Transposons offer the potential benefits of ease of phar-
maceutical formulation and scale up since only DNA, or
DNA and RNA encoding the transposase need to be pro-
duced. This approach may also produce vectors that are
less immunogenic than are viral vectors making repeated
administration more likely to be successful than with viral
vectors. Again the issues of carrying capacity, target site
preference for integration, and influence of transposon
vector sequences on the expression of transgenes andReproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/80
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endogenous genes is critical for this application of trans-
poson technology.
The third application of transposon technology is the
insertional mutation of endogenous genes for genetic
screens. This approach has been extensively pursued for
genetic studies in invertebrates such as Drosophila mela-
nogaster and in many plant species [7–10]. The advantage
of such a system is that germline mutations caused by
transposon insertion are molecularly tagged, greatly facil-
itating their molecular identification. This advantage is in
stark contrast to germline mutagenesis using X-irradiation
or chemicals, which often do not leave any easily identifi-
able trace of their activity or create such large chromo-
somal rearrangements or deletions as to affect multiple
genes at one time. One of the best chemical mutagens for
vertebrate germline mutagenesis is ethyl nitrosourea
(ENU), an ethylating agents that generally causes single
base pair mutations [11]. When used to treat fertile male
mice for instance, ENU can mutate the average locus in
one in every 750 to one in every 1500 gametes, making it
an incredibly powerful mutagen [11]. Even so, each dom-
inant or recessive mutation must be mapped to high reso-
lution using meiotic recombination until a sufficiently
small critical region of the genome is identified, usually
much less than 1 cM in size. At this point, candidate genes
in the region are laboriously screened for mutations by
directly sequencing exons and splice junctions. Thus, gene
identification remains a major bottleneck in ENU muta-
genesis projects. Another advantage of transposon inser-
tional mutagenesis is the ability to engineer special
vectors that can express a reporter molecule in a context-
dependent manner. Such vectors are often called "gene-
traps" and can be designed to express a reporter gene if
and only if insertion occurs in the right place and orienta-
tion. The three major types of gene-traps are: 1. enhancer
traps, 2. promoter or 5' gene traps and 3. polyadenylation
site or 3' gene traps. Enhancer traps contain a very weak
promoter driving a reporter molecule, which if inserted
near a gene can come under the influence of endogenous
enhancer elements. The result is the temporal and/or tis-
sue-specific expression of the reporter in transgenic ani-
mals. Enhancer trapping has been widely used in
Drosophila melanogaster to create lines of flies expressing
the GAL4 transcription factor in tissue specific patterns. In
this way, a large number of so-called GAL4 driver lines can
be bred with lines carrying other transgenes under the
control of promoters containing upstream activating
sequences (UAS) responsive to GAL4 [12]. Similar sys-
tems could be devised for use on vertebrate model organ-
isms, perhaps based on GAL4/VP16 or tetracycline
transactivator/VP16 fusions [13]. Promoter or 5' gene-
traps created using transfected plasmid DNA or retroviral
transduction have been widely pursued in cultured mouse
embryonic stem (ES) cells to create large libraries of
clones, each with one disrupted gene [14–17]. For this
work, the vectors contain a splice acceptor followed by a
gene conferring resistance to an antibiotic such as puro-
mycin or G418. Thus, insertions into genes can be selected
for in culture and the inserted gene is mutated since splic-
ing into the plasmid or retroviral vector produces a trun-
cated fusion transcript. Alternatively, 3' or
polyadenylation site traps contain an internal promoter
driving a reporter molecule or antibiotic resistance gene
followed by a splice donor but lack any splice acceptor or
polyadenylation sequence [17]. If the vector inserts into a
gene-free region, then it's reporter protein will not be
expressed, because the transcript is neither spliced nor
polyadenylated, resulting in poor export from the nucleus
and RNA instability. If the vector inserts within a gene and
in the same orientation as that gene, then splicing to
downstream exons results in the production of a stable
fusion transcript that is spliced and polyadenylated, thus
the reporter protein is expressed. In this way, ES clones
can be selected that harbor insertions into genes, even if
that gene is not expressed in ES cells. It should be noted
that 3' traps are not thought to be highly mutagenic unless
they contain an upstream 5' trap to efficiently truncate the
endogenous gene [17]. Each of these three gene trapping
vectors could be pursued for use in transposons for verte-
brate germline mutagenesis. For this application, mobili-
zation of chromosomally resident transposons in
transgenic animals has the advantage of allowing new
gene insertions to be obtained simply by breeding. Thus,
true forward genetic screens could be performed in which
phenotypes were identified first and then gene identifica-
tions made second. A critical issue for using any transpo-
son for the purpose of germline insertional mutagenesis is
the frequency of transposon mobilization. Too few inser-
tions per gamete means that too few useful offspring are
obtained, thus wasting animal resources and resulting in
inefficiency. Too many insertions per gamete means that
multiple, perhaps linked, genes could be mutated in the
same animal. This will complicate identification of the
insertion responsible for a given phenotype. Also critical
for this application of transposon technology is a thor-
ough understanding of the target site choice of the vector
within the genome, with regard to the location of the
donor site, transcribed versus non-transcribed regions,
and within the genes into which it becomes inserted. For
instance, some transposons, when mobilized from a chro-
mosomal site, tend to insert within a local region near the
donor site [18,19] (Carlson et al., Genetics, In Press). This
effect will bias toward mutagenesis in a particular region
of the genome. While this could be an advantage, local
hopping would have an influence over a whole-genome
screen.
What follows is a review of the transposable elements that
have been shown to work in various applicationsReproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/80
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described above in vertebrate cell lines or animals. In the
conclusion section, some predictions are made as to
future development of these and other transposons for
creating and manipulating transgenic animals.
L1 Elements
Among the vertebrate retrotransposable elements, the
long interspersed repetitive elements (LINEs) have been
extensively characterized and have been engineered for
gene transfer and insertional mutagenesis [3]. LINEs are
particularly abundant in the human genome with approx-
imately 350,000 copies. Almost all of these elements are
inactive due to mutations in the promoter or one or both
of its two open reading frames. However, LINEs remain
active in the human genome, and can in fact cause inher-
ited genetic disorders [3]. It is estimated that up to 1% of
human genetic mutations are due to LINE insertions. In
contrast, mouse LINEs are much more active, causing per-
haps 10% of mouse germline mutations [3,20]. The
human L1 element promoter is active only in germline
cells, but a heterologous promoter can be used to drive
expression of the L1 transcript [21]. By cloning an L1 ele-
ment, from an insertion into the factor VIII gene from a
hemophilia A patient, Dr. Haig Kazazian's laboratory was
able to isolate an active L1 element [21]. This vector was
cloned and altered so that a reverse orientation, intron-
interrupted, neomycin resistance gene (NEO) with a het-
erologous promoter was placed in the 3' UTR. After one
round of transcription, splicing, reverse transcription, and
integration, the NEO gene can be expressed and confers
resistance to G418 selection. This cloned and altered L1
retrotransposon vector was shown to have activity in cul-
tured human and mouse cells [21]. An altered version of
this L1 retrotransposon was then constructed in which
NEO was replaced by the gene for the green fluorescent
protein (GFP) driven by the acrosin promoter [22]. In this
way, retrotranspositon could be followed by the appear-
ance of GFP positive cells. When transgenic mice were
created with this L1/GFP element, an examination of
sperm cells revealed a fairly high frequency of GFP+ cells.
When these mice were bred to wild type females, approx-
imately one in sixty offspring harbored new L1 vector
insertions [22]. Potential advantages of this system
include the fact that the entire genome potentially could
be mutagenized using the L1 vector without bias to one
chromosome or chromosome region, more insertions per
genome might be obtained using recently identified more
active L1 elements [23], and increases in transcription
might provide increases in insertion rate. Current disad-
vantages include the relatively low number of insertions
per gamete obtained so far, the fact that the 3' UTR of the
L1 vector may tolerate only a limited amount of foreign
sequence, the frequent 3' truncation of L1 vectors upon
retrotransposition [21], and the fact that L1 insertion is
often accompanied by deletion of sequences at the inser-
tion site [24]. L1 vectors might be useful for introducing
genes into somatic cells and have been cloned into aden-
oviral vectors, which can efficiently deliver L1 vectors to
human cultured cell lines, resulting in retrotransposition
into the genome [25].
hAT Elements: Tol2
In 1996, Dr. H. Hori's lab in Japan reported the isolation
of a vertebrate transposon of the hobo-Activator-Tam3
(hAT) family of transposable elements inserted into the
tryosinase gene of a strain of albino Medaka fish [26]. Sub-
sequent research has shown that this element is indeed
autonomous [27,28]. Tol2 is the first, and to date only,
naturally occurring active cut-and-paste transposon iso-
lated from vertebrates. However, an examination of
endogenous Tc1/mariner-like zebrafish transposons sug-
gests that some are active [29]. The Tol2 transposase gene
is produced from a singly spliced transcript. The Tol2
transpoase gene can be produced from a heterologous
promoter, while the transposon itself can be altered so
that it contains a foreign gene cassette [27]. This two-part
system can thus be used for a variety of gene transfer pur-
poses. To date highly efficient germline transgenesis of the
Zebrafish, Dana rario, has been achieved by co-injection of
in vitro transcribed mRNA for the transposase with trans-
poson vector DNA into the one cell embryo [27]. This
method helps provide a system for efficient fish transgen-
esis, which is normally very inefficient by injection of
plasmid DNA alone (Steve Ekker, personal communica-
tion). The Tol2 element may be active in mammalian
cells, especially given the precedent for activity in human
and mouse cells of a fish cut-and-paste transposon pro-
vided by study of Sleeping Beauty [4,30,31]. Indeed, Tol2
mediated excision, but not full transposition, has already
been demonstrated in human and mouse cells [32]. It
remains to be determined if the Tol2 transposase can be
expressed as a transgene in the germline of transgenic ani-
mals and allow the mobilization of chromosomally resi-
dent transposon vectors. Potential advantages of Tol2 for
germline mutagenesis include the fact that hAT elements
have been shown to have the capacity to transpose very
large vectors [33], and the fact that it is a naturally occur-
ring element and so may be more active than recon-
structed elements. Recent studies of the hobo element
suggest that it has distinct hot spots for integration and
that the percentage of the genome available for insertion
is more restricted than for other transposable elements
such as the P element [33,34].
Tc1/mariner Elements: Mariner (Himar1, Mos1), Tc1, Tc3, 
Minos, Sleeping Beauty
The Tc1/mariner family is a large family of widely distrib-
uted "cut-and-paste" transposable elements flanked by
inverted terminal repeats, which in some cases themselves
have embedded direct repeat sequences (for review seeReproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/80
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[1]). These elements have been found in all vertebrate
genomes examined, but are in all cases defective, contain-
ing frameshift mutations, stop codons and small or large
deletions in the transposase gene. A lot of research has
been invested into this family of transposons based upon
investigations into the active proto-typical Tc1, from
Ceanorhabditis elegans, and mariner elements, such as
Mos1 from Drosophila mauritania. Members of this family
contain a transposase with a DNA binding domain dis-
tantly related to the paired-box DNA binding domain. In
addition, a catalytic DDE domain has been identified and
critical amino acids in this domain have been discovered
[1].
The mariner and Tc1 transposases have been purified, and
remarkably, can be combined with a transposon DNA
substrate, which will then undergo transposition in vitro
without a requirement for any other proteins [35,36]. Two
closely related versions of mariner have been well studied,
Mos1 and Himar1, but are widespread in insects [37]. The
Himar1 element is a consensus sequence based on several
clones isolated from the horn fly, Haematobia irritans, and
Mos1 was isolated from Drosophila mauritania [35]. The
wide distribution of Tc1/mariner transposons, the ability
of mariner to function in vitro in purified form and in dis-
tantly related species, suggested that such elements might
require no co-factors for transposition in cells, or use very
highly conserved host factors. For example, Mos1 has
been introduced into the distantly related insect species,
such as the yellow fever mosquito Aedes aegypti [38]. For
these reasons, great enthusiasm exists for adapting Tc1/
mariner-like transposons for use in vertebrate species.
Indeed mariner, Tc1 and Tc3 show activity in cultured
mouse and human cell lines [39,40]. A screen for hyper-
active mutants in E. coli resulted in the identification of
amino acid substitutions that improve the activity of
Himar1 in cultured cells [41]. The Mos1 mariner transpo-
son has been used to achieve germline transgenesis in the
chicken [5]. Both mariner and Tc3 has been used to
achieve germline transgenesis in zebrafish [42,43]. The
purified Himar1 transposase efficiently catalyzes inter-
plasmid transposition [35]. The same kind of interplas-
mid transposition assay was used in a human 293T
embryonic kidney cell line, showing that Himar1 transpo-
sition can occur in mammalian cells [44]. While Himar1
is primarily used for insertional mutagenesis in bacteria
and mycobacteria, its potential for vertebrate gene transfer
and insertional mutagenesis remains unclear. It remains
to be determined if the active mariner elements, Tc1, or
Tc3 can be used to mobilize chromosomally resident
transposon vectors in vertebrates.
The Minos element, a Tc1/mariner-like transposon from
Drosophila hydei, has been shown to be active in cultured
human cell lines [45,46]. A gene-trap Minos transposon
has been constructed and a library of insertions in HeLa
cells were obtained [46]. The Minos transpoase gene has
been expressed in transgenic mice from B cell lineage spe-
cific and male sperm cell specific promoters [47,48].
When these mice were crossed with transgenic mice carry-
ing Minos transposon vectors, transposition occurred in B
cells and in the male germline respectively. Germline
insertions occurred in rough one in every ten offspring.
Several germline insertions were cloned and each was
found to be on a different chromosome [48]. These data
suggest that Minos might be useful for mouse germline
mutagenesis and that no distinct preference for local
transposition occurs using this transposon system. Thus,
genome-wide insertional mutagenesis with Minos is a real
possibility in the mouse and possibly other species as
well.
The Sleeping Beauty transposon (SB) is a synthetic Tc1/
mariner family transposon derived from defective ele-
ments cloned from various Salmonid fish genomes [30].
The development of SB is particularly significant because
it is the first vertebrate transposable element reconstructed
from defective endogenous elements. This was accom-
plished by the stepwise repair of the open reading frame,
nuclear localization signal, DNA binding domain, and
catalytic activity. Because this process required ten major
steps, the SB transposase was designated SB10. SB has
been extensively studied. A model of the SB transposition
reaction has been proposed based on studies of its
inverted terminal repeat structures [49]. As part of this
study an improved inverted terminal repeat sequence,
designated pT2, was discovered [49]. SB related trans-
posons have complicated inverted terminal repeats, each
with two embedded direct repeats called the inner direct
repeats and the outer direct repeats. The direct repeats,
which are ~25 base pairs long, are the sites of transposase
binding [30]. Neither the inverted repeats nor the direct
repeats are perfect, and clear differences exist between the
right and left inverted repeats and between the inner and
outer direct repeats. The rules governing the transposition
are not completely understood, but higher binding activ-
ity does not translate into increased transposition [49]. In
addition, continued examination of the SB10 transposase
sequence led to the identification of additional amino
acid substitutions that confer increased activity in gene
transfer into transfected HeLa cells [50]. SB transposons
have been used to achieve germline transgenesis in the
mouse [4]. In these experiments, one-cell mouse embryo
pronuclei were co-injected with transposon vector DNA
and in vitro transcribed mRNA encoding the SB10 trans-
posase. The overall transgenesis rate was increased 1.5
fold over background without transposase. The increase in
transgenesis rate was entirely due to offspring with multi-
ple, independent transposon insertions. An average of
three insertions per animal was obtained in some experi-Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/80
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ments and transposon transgenes could be expressed.
However, the transgenes within transposon vectors seem
to be subject to position effect variagation, just as are
standard mouse transgenes. These data showed that mam-
malian germline transgenesis by transposition is possible
and suggest that the SB system might find utility in other
mammalian species in which transgenesis is difficult.
Another application of SB has been somatic cell transgen-
esis. SB can be used for stable, long-term gene transfer and
expression into the liver of adult mice [51]. In some exper-
iments, the SB transposon vector and transposase trans-
gene have been delivered by so-called "hydrodynamic
therapy". In this approach, 10% of the weight of the
mouse of DNA-containing Ringer's solution is injected via
the tail vein into mice in less than ten seconds. For the
average mouse this is roughly 2–2.5 milliliters. The result-
ant transient increase in venous pressure within the liver
is thought to result in extravasation of the plasmid DNA,
which is efficiently taken up by ~25% of hepatocytes [52].
The Factor IX gene was cloned into an SB transposon vec-
tor and delivered to hemophilia B knockout mice using
this technique by Dr. Mark Kay's laboratory [51]. Long-
term expression required co-delivery of the Factor IX
transposon and an active SB10 transposase gene on
another plasmid. Similar success has been achieved for
long-term gene transfer of the FAH gene into knockout
mouse liver [53], and the LAMB3  gene into cultured
human skin cells from patients with junctional epidermo-
lysis bullosa syndrome to correct this disorder in
xenografted nude mice [54]. Dr. Mark Kay's group also
has developed "binary" gene therapy vectors in which
both the SB transposon vector and SB10 transposase gene
were delivered to hepatocytes using adenoviral vectors,
which by themselves only result in transient gene transfer
and expression [31]. Interestingly, efficient gene transpo-
sition required recombinase-mediated excision and circu-
larization of the transposon vector from the linear
adenoviral DNA, suggesting that circularized transposon
vector DNA is more efficiently transposed, at least in this
environment [31]. Dr. Scott McIvor's laboratory has
developed methods for long term gene transfer and
expression into adult mouse lung using SB vector and
SB10 transposase DNA complexed with
polyethyleneimine (PEI), a polycationic, branched mole-
cule (Beleur et al., Molecular Therapy, In Press). Finally, in
the area of germline insertional mutagenesis, we have
demonstrated that SB transposons present in chromo-
somes of SB transposase transgenic mice will efficiently
undergo transposition in germline cells, such that off-
spring from these mice are obtained with new transposon
insertions [55]. Similar results were published in 2001 by
two other labs using SB, one in Japan and one in the Neth-
erlands [19,56]. Three papers all report essentially similar
results, with differences in the average number of new
transposon insertions obtained. The ubiquitously
expressed CAGGS [55,56], or the male germline specific
protamine 1 promoters [19] were used to drive expression
of the SB transposase. Single copy [19] or multicopy trans-
poson vectors were used, all with different internal
sequences in the transposon itself. An average of 0.2 [19],
1 [56], or 2.0 [55] new transposon insertions per offspring
were obtained. These data clearly establish that the SB sys-
tem can be used to achieve high efficiency transposition in
the male or female germline. When we bred animals with
new transposon insertions they were present in roughly
half of the offspring of these animals and could segregate
independently as if they had transposed to multiple chro-
mosomes. Moreover, if the animal bred was also trans-
genic for the SB10 transposase, then a number of new
transposon insertions were detected. It is important to
note that offspring are generated with as many as 11 new
transposon insertions, when the transposon concatomer
is passed through the germline twice in the presence of the
transposase transgene (unpublished data). To be useful as
insertional mutagens, SB transposon vectors should be
capable of inserting into genes. Indeed, transposon vector
insertion into genes has been observed in primary mouse
liver cells [51] and in cultured cell lines. Using inverse
PCR or a linker-mediated PCR technique [55] we have
cloned and sequenced 44 germline transposon insertions
and analyzed them and mice carrying these insertions
(Carlson et al., Genetics, In Press). All the insertions
cloned are flanked by TA dinucleotides as expected for
Tc1/mariner family transposition. Analysis of the transpo-
son insertions showed that the adjacent plasmid sequence
from the concatomer had been replaced by mouse
genomic sequence as expected if true transposition had
occurred. The distribution and sequence content flanking
these cloned insertion sites was compared to 44 mock
insertion sites randomly selected from the genome. We
found that germline SB transposon sites are AT-rich and
the sequence ANNTANNT is favored compared to other
TA dinucleotides. Local transposition occurs with inser-
tions linked to the donor site roughly 40% of the time.
The size of this local hopping interval is roughly 3–5 cM
or 10–12 Mbp. We find roughly 30% of the transposon
insertions are in transcription units as determined using
the Celera database, similar to the percentage of random
TA dinucleotides. We also determined that transposons
inserted within a gene, in the same orientation as the
gene, are subject to splicing from upstream exons of the
endogenous gene. Significantly, we now know how often
transposon insertions occur within genes (~25–30% of
the time), how often a transposon insertion occurs locally
near the donor site (~50% of the time), and how big the
local region is for SB-mediated transposition (~3–5 cM or
10–15 Mbp). The results are all consistent with the use of
SB for forward genetic screens in local intervals of the
mouse genome. Thus, assuming 2 new transposon inser-
tions per gamete (as we have already achieved) we canReproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/80
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expect to achieve a 1X coverage of a 10 Mbp region of the
genome (with one insertion every 10 kb) in as few as 1000
mice. We have begun to characterize two embryonic lethal
mutations caused by endogenous splicing disruption in
mice carrying intron-inserted SB gene-trap transposons. It
is clear from these analyses that SB and probably other
cut-and-paste transposons have potential utility as ran-
dom germline mutagens for forward genetic screens.
Conclusions and Future Directions
It is very likely that transposon technology will have an
impact in one or more of the three applications described
in this review over the next several years. This progress
may involve use of one or more of the transposon systems
described above or may involve new transposon systems.
The precedent set by work on SB shows that evolutionarily
defunct transposons can be "resurrected" using reverse
evolutionary principals. This means that many other
potentially useful transposons could be derived from a
purely informatics based approach using sequenced
genomes. A rich source of new transposon systems could
be generated in this way, some of which may have
attributes more suited to one or another application.
Alternately, it is likely that many species contain active
elements, such as Tol2 and L1, since we see the evidence
of their past activity in all genomes examined. Again, the
search for these active elements will be a useful outcome
of ongoing genome projects. Mammalian or avian germ-
line transgenesis by transposition could have an impact
on several agriculturally relevant species. Transgenesis for
most of these species is currently very difficult or impossi-
ble. Given the technical challenges of harvesting, manipu-
lating, and injecting early embryos from some of these
species, it is worth considering sperm transgenesis by
transposition. This process has been achieved in mice via
micro-injection [57], and might be made more efficient
using transposon vectors. While the risk of insertional
mutagenesis, specifically activation of endogenous proto-
oncogenes and cancer, are present with transposons used
in gene therapy [58], it remains to be determined if they
are low of enough compared to the benefits that transpo-
son-based gene therapy may bring. However, it is clear
from work using SB that the concept is sound from a
technical standpoint. Finally, transposon-mediated inser-
tional mutagenesis of the mouse germline is clearly
possible with SB, Minos and probably Tol2. Transposon-
based germline mutagenesis might also be considered for
other species, particularly those for which ES cells cannot
be easily obtained. In the mouse, however, the best use of
each system probably depends upon the type of screen
desired. The maximal number of insertions per gamete
that can be reliably obtained must be determined. The
ideal sequences for gene-trapping must be identified.
Applications such as local saturation mutagenesis or chro-
mosome engineering by placement of LoxP sites within
transposon vectors are certainly possible. It is hoped that
such approaches can led to significant contributions to
functional annotation of the mammalian genome in the
future.
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